Key result
Losartan reduced hypertension by approximately 20% and sympathoexcitation by 41% in 2K-1C rats, likely via preferential reduction of oxidative stress in the RVLM.
Why the study?
Does losartan reduce oxidative stress and cardiovascular dysfunction in rats with renovascular hypertension?
Does losartan reduce oxidative stress and cardiovascular dysfunction in rats with renovascular hypertension?
Losartan reduces hypertension and sympathoexcitation in renovascular hypertensive rats, partly by decreasing oxidative stress in the rostral ventrolateral medulla.
Answers are grounded in this paper and cite their sources.
Losartan attenuates renovascular hypertension in rats via RVLM oxidative stress; hypothesis-generating and should not change clinical practice.
BACKGROUND: Previous studies showed that the microinjection of antioxidants or the overexpression of superoxide dismutase within the rostral ventrolateral medulla (RVLM) reduces hypertension and sympathoexcitation in the 2-kidney, 1-clip (2K-1C) model. In this study, we hypothesized that angiotensin II (ANG II) type 1 receptor (AT1R) is involved in the oxidative stress within the RVLM and contributes to cardiovascular dysfunction in renovascular hypertension. METHODS: Losartan (30mg/kg/day, oral gavage) was administered for 7 consecutive days by week 5 after implantation of the clip (gap width = 0.2mm). Mean arterial pressure, baroreflex, and renal sympathetic nerve activity (rSNA) were evaluated. Superoxide production was evaluated by dihydroethidium (DHE) staining within the RVLM and within a control area. Systemic oxidative stress was characterized by measurement of thiobarbituric acid reactive substances (TBARS) and total glutathione (tGSH) in the blood. RESULTS: AT1R blockade significantly (P < 0.05) reduced hypertension by approximately 20% (n = 11) and sympathoexcitation to the kidneys by approximately 41% (n = 6) in the 2K-1C rats. Losartan treatment increased the baroreflex sensitivity of rSNA to pressor (67%) and depressor (140%) stimuli in the 2K-1C rats. AT1R blockade caused a significant (66%) reduction in DHE staining within the RVLM but not within the control area, reduced plasma TBARS (from 1.6±0.1 to 1.0±0.1 nmol/ml), and increased tGSH (from 3.4±0.4 to 5.2±0.3 μmol/g Hb) in the 2K-1C group only. CONCLUSIONS: Our findings suggest that the beneficial effects of ANG II blockade in renovascular hypertension are partly due to preferential reduction of oxidative stress in the RVLM.
No takes yet. Share an insight, caveat, or question.
Nishi et al. (2013) studied Renovascular hypertension. Losartan was evaluated on Hypertension and sympathoexcitation (p=< 0.05). Losartan reduced hypertension by approximately 20% and sympathoexcitation by 41% in 2K-1C rats, likely via preferential reduction of oxidative stress in the RVLM.
Synapse has enriched 10 related papers. Consider them for comparative context: